International Journal of Leprosy and other Mycobacterial Diseases

1- The histological course of reactions in borderline leprosy and their outcome

Dennis S. Ridley; K. B. Radia

• PDF

2- A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy

Diltor Vladimir Araujo Opromolla; Claudio Joaquim Sampaio Tonello; A. Colin McDougall; S. J. Yawalkar

• PDF

3- Electrophysiologic and histologic studies in leprosy and some acrodystrophic neuropathies

S. S. Pandya; R. G. Chulawala

• PDF

4- Isolation and identification of mycolic acids in Mycobacterium leprae and Mycobacterium lepraemurium

Takashi Kusaka; Kenji Kohsaka; Yukiko Fukunishi; Hiromi Akimori

• PDF

5- The problem of dapsone-resistant leprosy

John M. H. Pearson

• PDF

6- Dapsone-resistant leprosy-the THELEP approach

• PDF

7- Primary dapsone-resistant leprosy in Cebu, Philippines

Ricardo S. Guinto; R. V. Cellona; T. T. Fajardo; E. C. de la Cruz

• PDF

8- Report of the third meeting of the Scientific Working Group on Chemotherapy of Leprosy (THELEP) of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, Geneva, 20-22 October 1980

• PDF

9- Immunogenetics of susceptibility to leprosy, tuberculosis, and leishmaniasis. an epidemiological perspective

Paul E. M. Fine

• PDF

10- In vitro stimulation of human lymphocytes with mycobacterial antigens

E. P. Wright; Radhika Rangarajan

• PDF

11- DDS 100 mg daily, the cornerstone in the management of reversal reaction

J. van der Meulen; B. Mock

• PDF

12- Reply to Dr. van der Meulen and Dr. Mock's Letter to the Editor

Ben Naafs

• PDF

13- News and Notes

• PDF

14- Reviewers

• PDF

15- Current Literature

• PDF

16- Sixteenth joint leprosy research conference

Masahide Abe

• PDF

17- Acknowledgment

• PDF

18- Statement of ownership, management, and circulation

W. Felton Ross

• PDF